Seeking Alpha
  • Adam Gefvert, CFA
    I'm short OREX, ARNA's approval is actually a bad sign for them.
    6/27/12
    Reply (9)
    • Spencer Knight: That's what I'm saying. I see both sides. If Contrave makes it to market it will be great for OREX. Still ARNA's approval is bad for OREX.
      6/27/12
    • Adam Gefvert, CFA: Then Qnexa will get approved. By the time Contrave gets approved, there's no more market share.
      6/27/12
    • Maria Auziliadora: yes no good for OREX and they are not even closed for approval
      6/27/12
    • Spencer Knight: That's what I've been saying about lorcaserin as well. If qnexa is approved it will take away some of lorcaserin's luster.
      6/27/12
    • FortSumter: Shorted OREX via July $4.50 put. Doesn't seem rational to compare biotechs as equal trades like retail or oil stocks.
      6/27/12
    • Maria Auziliadora: Spencer that's why I think ARNA didn't fly to crazy levels because we still have Qnexa in the horizon One thing though VVUS stock is high!!
      6/27/12
    • Maria Auziliadora: now OREX is flying
      6/28/12
    • Adam Gefvert, CFA: Yea, it's having a good day now. Biotech is tough.
      6/28/12
    • Adam Gefvert, CFA: ARNA wasy down, go figure.
      6/28/12